HMG CoA reductase inhibitors (statins) for kidney transplant recipients

Sankar D. Navaneethan; Vlado Perkovic; Sagar U Nigwekar; David W. Johnson; Jonathan C. Craig; Giovanni F.M. Strippoli

HMG CoA reductase inhibitors (statins) for kidney transplant recipients

Sankar D. Navaneethan, Vlado Perkovic, Sagar U Nigwekar, David W. Johnson, Jonathan C. Craig, Giovanni F.M. Strippoli

Flinders University

Research output: Contribution to journal › Review article › peer-review

69 Citations (Scopus)

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

To evaluate the effects of statin therapy on mortality and the risk of subsequent cardiovascular outcomes in kidney transplant recipients

To evaluate the effects of statin therapy on graft function, including the incidence of acute rejection and chronic allograft nephropathy.

To evaluate the effects of statin therapy on the risk of acute transplant rejection.

To evaluate the risk of drug or dosage related adverse events when statin therapy is used in kidney transplant recipients.

Original language	English
Article number	CD005019
Journal	Cochrane Database of Systematic Reviews
Issue number	2
Publication status	Published - 21 Jan 2009

Keywords

kidney transplantation
cardiovascular disease
Lipoprotein profile

Fingerprint Dive into the research topics of 'HMG CoA reductase inhibitors (statins) for kidney transplant recipients'. Together they form a unique fingerprint.

Cite this

@article{bbe13ce24def4c6da20540f689c40e8c,

title = "HMG CoA reductase inhibitors (statins) for kidney transplant recipients",

abstract = "This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the effects of statin therapy on mortality and the risk of subsequent cardiovascular outcomes in kidney transplant recipients To evaluate the effects of statin therapy on graft function, including the incidence of acute rejection and chronic allograft nephropathy. To evaluate the effects of statin therapy on the risk of acute transplant rejection. To evaluate the risk of drug or dosage related adverse events when statin therapy is used in kidney transplant recipients.",

keywords = "kidney transplantation, cardiovascular disease, Lipoprotein profile",

author = "Navaneethan, {Sankar D.} and Vlado Perkovic and Nigwekar, {Sagar U} and Johnson, {David W.} and Craig, {Jonathan C.} and Strippoli, {Giovanni F.M.}",

year = "2009",

month = jan,

day = "21",

language = "English",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "UPDATE SOFTWARE LTD",

number = "2",

}

TY - JOUR

T1 - HMG CoA reductase inhibitors (statins) for kidney transplant recipients

AU - Navaneethan, Sankar D.

AU - Perkovic, Vlado

AU - Nigwekar, Sagar U

AU - Johnson, David W.

AU - Craig, Jonathan C.

AU - Strippoli, Giovanni F.M.

PY - 2009/1/21

Y1 - 2009/1/21

N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the effects of statin therapy on mortality and the risk of subsequent cardiovascular outcomes in kidney transplant recipients To evaluate the effects of statin therapy on graft function, including the incidence of acute rejection and chronic allograft nephropathy. To evaluate the effects of statin therapy on the risk of acute transplant rejection. To evaluate the risk of drug or dosage related adverse events when statin therapy is used in kidney transplant recipients.

AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the effects of statin therapy on mortality and the risk of subsequent cardiovascular outcomes in kidney transplant recipients To evaluate the effects of statin therapy on graft function, including the incidence of acute rejection and chronic allograft nephropathy. To evaluate the effects of statin therapy on the risk of acute transplant rejection. To evaluate the risk of drug or dosage related adverse events when statin therapy is used in kidney transplant recipients.

KW - kidney transplantation

KW - cardiovascular disease

KW - Lipoprotein profile

M3 - Review article

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

SN - 1469-493X

IS - 2

M1 - CD005019

ER -